Clinical trial
Prazosin for ETOH or Cocaine Craving
NCT00240227 · US Department of Veterans Affairs, U.S. Fed · Terminated
Key facts
| NCT number | NCT00240227 |
|---|---|
| Title | Prazosin for ETOH or Cocaine Craving |
| Official title | The Role of the Alpha 1-adrenergic Antagonist, Prazosin, in the Reduction of Craving and Relapse in Alcohol and Cocaine-dependent Individuals: a Double-blind, Randomized, Controlled Clinical Trial |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Alcoholism, Cocaine Dependence |
| Intervention type | Drug |
| Interventions | Prazosin, placebo |
| Enrollment | 8 |
| Start date | Apr 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Oct 17, 2005 |
| Last update posted | Aug 31, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: